You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

~ Buy the ORENITRAM (treprostinil diolamine) Drug Profile, 2024 PDF Report in the Report Store ~

Drug Price Trends for ORENITRAM

✉ Email this page to a colleague

« Back to Dashboard

Best Wholesale Price for ORENITRAM

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions

Subscribe to access the full database, or Sign Up

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Unit	Dates	Price Type
ORENITRAM EXTENDED RELEASE TABLETS 2.5MG	United Therapeutics Corporation	66302-0325-10	10	1108.49	110.84900	EACH	2021-01-01 - 2025-03-31	FSS
ORENITRAM EXTENDED RELEASE TABLETS 0.25MG	United Therapeutics Corporation	66302-0302-10	10	79.95	7.99500	EACH	2021-01-01 - 2025-03-31	Big4
ORENITRAM EXTENDED RELEASE TABLETS 0.125MG	United Therapeutics Corporation	66302-0300-02	10	58.15	5.81500	EACH	2023-05-01 - 2025-03-31	FSS
ORENITRAM MONTH 1 TITRATION KT	United Therapeutics Corporation	66302-0361-28	168	1221.14	7.26869	EACH	2023-05-01 - 2025-03-31	FSS
>Drug Name	>Vendor	>NDC	>Count	>Price ($)	>Price/Unit ($)	>Unit	>Dates	>Price Type

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.